Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 5, 2009

Premium

PerkinElmer appointed CEO and President Robert Friel to the additional job of chairman of its board of directors. The company said that the appointment is part of a leadership succession plan that it adopted in 2007. Friel succeeds Gregory Summe, who did not stand for re-election. Friel started at the company in 1999 as chief financial officer and he was promoted to president and chief operating officer in 2007. He took the CEO spot from Summe last year.

In addition, PerkinElmer this week appointed Frank Wilson to serve as CFO and chief accounting officer. Wilson assumes his new role on May 18. He was vice president of investor relations at Danaher, and previous to that was CFO of one of the businesses of AlliedSignal.


John Rossi, co-founder of Dicerna Pharmaceuticals, has been awarded the 2008 Cozzarelli Prize by the Proceedings of the National Academy of Sciences' editorial board. Rossi, who also is chair of the Department of Molecular Biology and dean of the Graduate School of Biological Sciences at City of Hope, received the award for work he outlined in a paper titled "MicroRNA-directed transcriptional gene silencing in mammalian cells."

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.